Literature DB >> 31699369

Inhibition of microtubule assembly competent tubulin synthesis leads to accumulation of phosphorylated tau in neuronal cell bodies.

Hitomi Fujiwara1, Shoji Watanabe2, Minori Iwata2, Shouyou Ueda1, Mika Nobuhara1, Satoko Wada-Kakuda1, Hiroaki Misonou3, Tomohiro Miyasaka4.   

Abstract

Neurofibrillary tangles, a pathological hallmark of Alzheimer's disease (AD), are somatodendritic filamentous inclusions composed of hyperphosphorylated tau. Microtubule loss is also a common feature of affected neurons in AD. However, whether and how the disruptions of microtubules and the microtubule-associated proteins occur in the pathogenesis of AD remain unclear. Recent evidence indicates that reduced expression of tubulin by knocking down a tubulin chaperon can cause tau neurotoxicity. Thus, the disruption of tubulin homeostasis may result in the acquisition of tau pathogenesis and ultimately cause tauopathy. To investigate whether the disruption of tubulin maintenance induces tau abnormalities in mammalian neurons, we developed a miRNA-mediated knockdown system of tubulin-specific chaperon E (Tbce), which is a factor required for the de novo synthesis of tubulin. Tbce knockdown in mouse primary cultured neurons induced an increase in tubulin in the cell body at 14 days in vitro. Accumulated tubulin was not acetylated or incorporated in microtubules, indicating that they were functionally inert. Concomitantly, tau also accumulated in neuronal cell bodies. The mis-localized tau was phosphorylated at Ser202/Thr205 and Ser396/Ser404. These results indicate that Tbce knockdown in mammalian neurons induces not only a reduction in properly folded tubulins, which are microtubule assembly competent, but also an accumulation of phosphorylated tau in the cell body of mammalian neurons. These findings suggest that disruption of the homeostatic mechanism for maintaining tubulin biosynthesis and/or microtubules can cause tau accumulation in the cell body, which is commonly observed in tauopathies.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Tau; Tauopathy; Tbce; Tubulin

Year:  2019        PMID: 31699369     DOI: 10.1016/j.bbrc.2019.10.191

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Protective effects of a small molecule inhibitor ligand against hyperphosphorylated tau-induced mitochondrial and synaptic toxicities in Alzheimer disease.

Authors:  Jangampalli Adi Pradeepkiran; Manne Munikumar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2021-12-27       Impact factor: 5.121

2.  Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE.

Authors:  Sofia Nolasco; Javier Bellido; Marina Serna; Bruno Carmona; Helena Soares; Juan Carlos Zabala
Journal:  Front Cell Dev Biol       Date:  2021-04-22

Review 3.  Modulatory Effects of Autophagy on APP Processing as a Potential Treatment Target for Alzheimer's Disease.

Authors:  Md Ataur Rahman; Md Saidur Rahman; M D Hasanur Rahman; Mohammad Rasheduzzaman; Anm Mamun-Or-Rashid; Md Jamal Uddin; Md Rezanur Rahman; Hongik Hwang; Myung-Geol Pang; Hyewhon Rhim
Journal:  Biomedicines       Date:  2020-12-24

4.  Hypoparathyroidism-retardation-dysmorphism syndrome-Clinical insights from a large longitudinal cohort in a single medical center.

Authors:  Odeya David; Rotem Agur; Rosa Novoa; David Shaki; Dganit Walker; Lior Carmon; Marina Eskin-Schwartz; Ohad S Birk; Galina Ling; Ruth Schreiber; Neta Loewenthal; Alon Haim; Eli Hershkovitz
Journal:  Front Pediatr       Date:  2022-07-22       Impact factor: 3.569

5.  Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer's Disease in an APP/PS1 Mouse Model.

Authors:  Qingyou Chen; Yue Yin; Li Li; Yanjiao Zhang; Wei He; Yan Shi
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-30       Impact factor: 2.570

6.  Disulfide bond formation in microtubule-associated tau protein promotes tau accumulation and toxicity in vivo.

Authors:  Taro Saito; Tomoki Chiku; Mikiko Oka; Satoko Wada-Kakuda; Mika Nobuhara; Toshiya Oba; Kanako Shinno; Saori Abe; Akiko Asada; Akio Sumioka; Akihiko Takashima; Tomohiro Miyasaka; Kanae Ando
Journal:  Hum Mol Genet       Date:  2021-10-13       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.